Legal Professionals: Get Listed!

What actions were taken by the FDA after Ketek was linked to severe liver complications?

The FDA approved a labeling supplement submitted by Aventis Pharmaceuticals as a "Changes Being Effected" (CBE) supplement, which highlights the 'Warnings' section of the labeling to raise attention to the risk of liver toxicity associated with Ketek.

Other Ketek FAQs

What Is Your Case Worth?

Change Your Location

Enter Your New Location:


(e.g., San Diego, CA or 92121 or 619)

Based on your IP Address, your default location is:

  • Area Code: 323
  • City: Los Angeles
  • State: CA